This is a preview of subscription content, log in via an institution to check access.
Reference
Long Y, et al. Durable complete response after afatinib and crizotinib in an advanced non-small cell lung cancer patient with EGFR L861Q mutation and acquired MET amplification: a case report. Annals of Palliative Medicine 9: 3609-3613, No. 5, Sep 2020. Available from: URL: http://doi.org/10.21037/apm-19-482
Rights and permissions
About this article
Cite this article
Afatinib/crizotinib. Reactions Weekly 1860, 23 (2021). https://doi.org/10.1007/s40278-021-97478-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-97478-2